RAPA-501-ALS-EAP: INTERMEDIATE-SIZE EXPANDED ACCESS TRIAL OF AUTOLOGOUS HYBRID TREG/TH2 CELL THERAPY (RAPA-501) OF AMYOTROPHIC LATERAL SCLEROSIS
Study specific tools and resources are linked below. You will want to bookmark this page for your reference! If you have any questions, comments, or requests, please contact biosend@iu.edu or by phone phone directly at (317) 278-6158.
General questions about the study, not related to the specimens, should be directed to Amanda Fonseca with Ozmosis Research.
| Visit | Screening/BL Day 0 | Apheresis | Cycle 1 Day 1 (D35) ± 14 | Cycle 2 Day 1 (D77) ± 14 | Cycle 3 Day 1 (D119) ± 14 | Cycle 4 Day 1 (D161) ± 14 | Follow-up (D190) ± 14 |
|---|---|---|---|---|---|---|---|
| Serum |
Study Resources
Please follow the below link to access the Kit Request Module. This link will direct you to a REDCap database where study coordinators and staff may request kits, individual supplies, and/or labels. Please allow a total of two weeks for kit requests to be fulfilled.
Please use the below link to access the collection and processing form for this protocol. This form must be completed prior to shipment. We also ask that all shipments include a physical copy of the shipping manifest portion of the form.
The below downloadable manual was created specifically for this study. Please feel free to explore the manual through the hyperlinked ‘Table of Contents’. Questions concerning any part of the manual may be directed to biosend@iu.edu for further clarification.
These slides correspond to the BioSEND training. Training is available upon request by contacting biosend@iu.edu.
BioSEND can receive samples Monday-Friday, excluding holidays. Frozen samples should be shipped M-W. Ambient samples may be shipped on Th.
Site Listing
- Emory University
- Massachusetts General Hospital
- University if Iowa
Looking for samples for your research? Check out BioSEND inventory of available samples.
Access samples at BioSEND